ISSUE: HTA is often focused on payers and may not prioritize attributes relevant to purchasers (e.g. employers and large provider organizations). Taking a US perspective, we will debate whether atypical models customized to purchaser type are needed to convey value.

OVERVIEW: Major health purchasers within the US are self-funded and hold fiscal responsibility for healthcare within their given populations. Health outcomes and economic research tools and presentations have typically centered on differences in clinical and safety presentation of products followed by economic differentiation. In recent years, there has been significant attention towards harmonization of value assessments in an effort to standardize the information set used to make healthcare purchasing decisions. However, these are typically focused on the HTA priorities of third party payers (health plans; PBMs). However, is this information what matters most to purchasers? Would an alternative evaluation approach addressing the needs of the purchaser rather than the payer be more appropriate? Which pathway would be more beneficial to showing potential gaps in care, gaps in coverage that could impact overall care of patients/members? The panel will debate these issues and present a case example of a purchaser-focused model.

Speaker presentation length of time is 10 minutes each.

Audience discussion and interaction with panel planned for the final 10 minutes.

Stakeholders that would benefit from attending are HEOR, Medical Affairs, Health Policy, Liaisons, Fellows, Senior Leaders, Product Managers